Recruiting Depression Studies in Lafayette
A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
This is a randomized, double-blind, active-controlled, multi-center study to evaluate the efficacy of AXS-05, compared to bupropion, in preventing the relapse of depressive symptoms in subjects with m...
Study of ALTO-300 in MDD
The purpose of this study is to determine efficacy differences between ALTO-300 and placebo, used adjunctively to an antidepressant, related to patient characteristics....
About Depression Clinical Trials in Lafayette
Depression (major depressive disorder) is a common and serious mood disorder that negatively affects how you feel, think, and handle daily activities. It affects over 280 million people globally. Treatment includes psychotherapy, antidepressant medications, and brain stimulation therapies.
There are currently 2 depression clinical trials recruiting participants in Lafayette, CA. These studies are seeking a combined 671 participants. Research is being sponsored by Axsome Therapeutics, Inc., Alto Neuroscience. Clinical trial participation is free and participants receive study-related medical care at no cost.
Depression Clinical Trials in Lafayette — FAQ
Are there depression clinical trials in Lafayette?
Yes, there are 2 depression clinical trials currently recruiting in Lafayette, CA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Lafayette?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Lafayette research site will contact you about next steps.
Are clinical trials in Lafayette free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Lafayette studies also compensate for your time and travel.
What depression treatments are being tested?
The 2 active trials in Lafayette are testing new therapies including novel drugs, biologics, and treatment approaches for depression.
Data updated March 2, 2026 from ClinicalTrials.gov